Timber Pharmaceuticals Analysis
Timber Pharmaceuticals is undervalued with Real Value of 0.0 and Hype Value of 0.0. The main objective of Timber Pharmaceuticals delisted stock analysis is to determine its intrinsic value, which is an estimate of what Timber Pharmaceuticals is worth, separate from its market price. There are two main types of Timber Pharmaceuticals' stock analysis: fundamental analysis and technical analysis.
The Timber Pharmaceuticals stock is traded in the USA on NYSE MKT Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Timber Pharmaceuticals is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, National Mourning Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Timber Stock trading window is adjusted to America/New York timezone.
Timber |
Timber Stock Analysis Notes
The company recorded a loss per share of 1.97. Timber Pharmaceuticals last dividend was issued on the 19th of May 2020. The entity had 1:50 split on the 9th of November 2022. Timber Pharmaceuticals LLC, a clinical-stage biopharmaceutical company, engages in the development and commercialization of treatments for orphan dermatologic diseases. The company was founded in 2019 and is headquartered in Basking Ridge, New Jersey. Timber Pharmaceuticals operates under Biotechnology classification in the United States and is traded on AMEX Exchange. It employs 5 people. To find out more about Timber Pharmaceuticals contact John MBA at 973 314 9577 or learn more at https://www.timberpharma.com.Timber Pharmaceuticals Investment Alerts
| Timber Pharmaceuticals is not yet fully synchronised with the market data | |
| Timber Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Timber Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 83.18 K. Net Loss for the year was (19.38 M) with loss before overhead, payroll, taxes, and interest of (5.26 M). | |
| Timber Pharmaceuticals currently holds about 11.22 M in cash with (15.85 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.78. |
Timber Pharmaceuticals Upcoming and Recent Events
| 27th of November 2023 Upcoming Quarterly Report | View | |
| 29th of March 2024 Next Financial Report | View | |
| 30th of September 2023 Next Fiscal Quarter End | View | |
| 29th of March 2024 Next Fiscal Year End | View | |
| 30th of June 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Timber Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 1.18 M.Timber Pharmaceuticals Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Timber Pharmaceuticals insiders, such as employees or executives, is commonly permitted as long as it does not rely on Timber Pharmaceuticals' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Timber Pharmaceuticals insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Pirozzi Gianluca over a year ago Acquisition by Pirozzi Gianluca of 4100 shares of Timber Pharmaceuticals subject to Rule 16b-3 |
Timber Pharmaceuticals Outstanding Bonds
Timber Pharmaceuticals issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Timber Pharmaceuticals uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Timber bonds can be classified according to their maturity, which is the date when Timber Pharmaceuticals has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 4875 Corp BondUS55336VAJ98 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View |
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Timber Pharmaceuticals to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Bond Analysis Now
Bond AnalysisEvaluate and analyze corporate bonds as a potential investment for your portfolios. |
| All Next | Launch Module |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Consideration for investing in Timber Stock
If you are still planning to invest in Timber Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Timber Pharmaceuticals' history and understand the potential risks before investing.
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |